Efficacy and Safety of Favipiravir in Management of COVID-19
Status:
Completed
Trial end date:
2020-06-20
Target enrollment:
Participant gender:
Summary
Randomized controlled interventional trial (Clinical Trial) phase 3 to assess the safety and
efficacy of favipiravir versus the standard care therapy in the treatment of patients with
COVID-19.